Page last updated: 2024-11-02

pentobarbital and Anti-MuSK Myasthenia Gravis

pentobarbital has been researched along with Anti-MuSK Myasthenia Gravis in 2 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
György, L1
Gellén, B1
Dóda, M1
Sterk, L1
Toso, A1
Cattani, C1
Massaria, E1

Other Studies

2 other studies available for pentobarbital and Anti-MuSK Myasthenia Gravis

ArticleYear
Pharmacology of 1-(2-oxo-1-pyrrolidino)-4-(2-chloroethyl-methylamino)but-2-yne-HCl (DSO-16), I. Its central cholinomimetic and cholinolytic effects on mice.
    Acta physiologica Academiae Scientiarum Hungaricae, 1971, Volume: 40, Issue:3

    Topics: Alkynes; Analgesia; Animals; Drug Antagonism; Drug Synergism; Female; Hexobarbital; Male; Methylamin

1971
[Anesthesiologic problems in the surgical therapy of myasthenia gravis by thymectomy].
    Minerva anestesiologica, 1969, Volume: 35, Issue:1

    Topics: Adolescent; Adult; Anesthesia, Endotracheal; Female; Halothane; Humans; Intubation, Intratracheal; M

1969